Chronic Kidney
Disease / Anemia

Female Hair Loss Treatment Study (Androgenetic Alopecia)

STUDY: A NEW ORAL TREATMENT (VDPHL01) FOR WOMEN EXPERIENCING HAIR THINNING.

At Unison, we are actively recruiting qualified participants for a study evaluating the efficacy of oral medication for female pattern hair loss. If you are interested and available, and you meet the qualifications outlined below, please contact us today.

Length of trial: Approximately 13 months (11 clinic visits)
Age range: 18 years or older
Condition qualifications:
Treatment: This trial is evaluating the same oral treatment (VDPHL01) in women with hair thinning. Participants will attend scheduled visits to monitor any changes in hair health and ensure treatment saftey.
All of our clinical trials are free of cost. No medical insurance is necessary and you may be compensated for your participation.

JOIN OUR PATIENT DATABASE

If you’re interested in joining one of our current or future clinical trials for patients with chronic kidney disease, please join our patient database today. We will review your information and reach out for a consultation if you qualify for the study.

SCHEDULE A CONSULTATION

INTEGRATIVE MEDICINE

Interested in participating in Clinical Trials? At Unison Medicine, we are constantly launching exciting clinical trials that are designed to evaluate the effectiveness and safety of new treatment approaches and drugs for conditions such as psoriasis, kidney disease, foot fungus, Tinea Pedis, Atopic Dermatitis, Acne, Psoriasis, Rosacea & IBS (Irritable Bowel Syndrome).

UNISON CLINICAL TRIALS